🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: * To describe the safety profile of the SP MenB vaccine...
Status
Terminated
Location
Lakeview Clinical Research Site Number : 8400029
Start Date
2021-03-29
Trial ID
NCT04825223
Treatments Being Tested
Primary objectives: To demonstrate that REPEVAX and VAXIGRIP administered ...
Status
Completed
Location
Sanofi Pasteur MSD Investigational Site
Start Date
2010-10
Trial ID
NCT01249183
Treatments Being Tested
This was a Phase II, randomized, open-label, multicenter study designed to ...
Status
Completed
Location
Univ of Alabama at Birmingham
Start Date
2006-01-23
Trial ID
NCT00282308
Primary Objective: To demonstrate the non-inferiority of the SHAN6™ vaccin...
Status
Completed
Location
Investigational Site Number 7640003
Start Date
2020-06-28
Trial ID
NCT04429295
Treatments Being Tested
Currently, there is no 5-component acellular pertussis vaccine licensed for...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT00467519
The purpose of the study is to provide data on the safety and immunogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00355654
Treatments Being Tested
The aim of the study is to assess the immunogenicity and safety profile of ...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01993173
This study is designed to assess the immunogenicity and safety of DTaP vacc...
Status
Completed
Location
Investigational site
Start Date
2014-04
Trial ID
NCT02118961
The study will evaluate the safety, immunogenicity，immune persistence and l...
Status
Active Not Recruiting
Location
Neihuang County Center for Disease Control and Prevention
Start Date
2021-10-22
Trial ID
NCT05091619
Treatments Being Tested